Skip to main content

Search

Join Our Contact Registry

Header Social Media

Our Research
Patients and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
- Latest News
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

Sign Up to Receive the GLIA-CTN Newsletter

Email Address

First Name

Last Name

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovationh (DRDI). GLIA-CTN is funded under grant number U54NS115052 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). All RDCRN consortia are supported by the network’s Data Management and Coordinating Center (DMCC) (U2CTR002818). Funding support for the DMCC is provided by NCATS and NINDS. The content of this website is solely the responsibility of the GLIA-CTN administrative coordinating center at Children’s Hospital of Philadelphia and does not necessarily represent the official views of the NIH.

social media